Henry Schein, Inc. $HSIC is Nuance Investments LLC’s 10th Largest Position

Nuance Investments LLC reduced its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 11.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 808,457 shares of the company’s stock after selling 102,006 shares during the quarter. Henry Schein accounts for 4.6% of Nuance Investments LLC’s portfolio, making the stock its 10th biggest holding. Nuance Investments LLC’s holdings in Henry Schein were worth $59,058,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of HSIC. Vanguard Personalized Indexing Management LLC raised its position in Henry Schein by 3.5% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company’s stock worth $341,000 after buying an additional 157 shares during the last quarter. Equitable Trust Co. boosted its holdings in shares of Henry Schein by 3.1% during the 2nd quarter. Equitable Trust Co. now owns 5,317 shares of the company’s stock valued at $388,000 after acquiring an additional 158 shares during the last quarter. TD Asset Management Inc grew its stake in shares of Henry Schein by 0.8% in the second quarter. TD Asset Management Inc now owns 22,016 shares of the company’s stock worth $1,608,000 after acquiring an additional 164 shares during the period. Radnor Capital Management LLC raised its holdings in shares of Henry Schein by 1.6% during the second quarter. Radnor Capital Management LLC now owns 11,415 shares of the company’s stock valued at $834,000 after purchasing an additional 180 shares during the last quarter. Finally, Simon Quick Advisors LLC lifted its position in Henry Schein by 5.5% during the second quarter. Simon Quick Advisors LLC now owns 3,466 shares of the company’s stock valued at $253,000 after purchasing an additional 182 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $71.90 on Friday. The stock has a 50-day simple moving average of $66.30 and a two-hundred day simple moving average of $68.74. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The firm has a market capitalization of $8.46 billion, a PE ratio of 23.19, a P/E/G ratio of 2.06 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 4th. The company reported $1.38 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.11. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.34 billion for the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. Analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analyst Weigh In

HSIC has been the subject of a number of research analyst reports. Wall Street Zen raised shares of Henry Schein from a “hold” rating to a “buy” rating in a research report on Saturday. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Henry Schein in a report on Friday, October 31st. Barrington Research set a $79.00 price objective on Henry Schein and gave the company an “outperform” rating in a research report on Wednesday. Wells Fargo & Company raised their target price on Henry Schein from $70.00 to $76.00 and gave the stock an “equal weight” rating in a research report on Wednesday. Finally, Morgan Stanley boosted their price target on Henry Schein from $55.00 to $58.00 and gave the company an “underweight” rating in a research note on Wednesday. Five research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $76.08.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.